Publicacións en colaboración con investigadores/as de Complexo Hospitalario Universitario da Coruña (33)

2024

  1. The multispecies microbial cluster of Fusobacterium, Parvimonas, Bacteroides and Faecalibacterium as a precision biomarker for colorectal cancer diagnosis

    Molecular Oncology, Vol. 18, Núm. 5, pp. 1093-1122

2018

  1. Experience with Sunitinib in metastatic renal cell carcinoma (mRCC) patients: pooled analysis from 3 Spanish observational prospective studies

    Expert Opinion on Drug Safety, Vol. 17, Núm. 6, pp. 573-579

2014

  1. Cabazitaxel for metastatic castration-resistant prostate cancer: Safety data from the Spanish expanded access program

    Expert Opinion on Drug Safety, Vol. 13, Núm. 9, pp. 1165-1173

  2. Cancer stem cells in genitourinary cancer

    Stem Cells in Cancer: Should We Believe or Not? (Springer Netherlands), pp. 149-165

2013

  1. Comprehensive overview of the efficacy and safety of sorafenib in advanced or metastatic renal cell carcinoma after a first tyrosine kinase inhibitor

    Clinical and Translational Oncology, Vol. 15, Núm. 6, pp. 425-433

  2. Erratum: Comprehensive overview of the efficacy and safety of sorafenib in advanced or metastatic renal cell carcinoma after a first tyrosine kinase inhibitor (Clinical and Translational Oncology DOI: 10.1007/s12094-012-0985-x)

    Clinical and Translational Oncology

2012

  1. Cytokine and endocrine signaling in prostate cancer

    Medical Oncology, Vol. 29, Núm. 3, pp. 1956-1963

2011

  1. Experience in the use of sunitinib given as a single agent in metastatic chemoresistant and castration-resistant prostate cancer patients

    Expert Opinion on Pharmacotherapy, Vol. 12, Núm. 16, pp. 2433-2439

2010

  1. Renal cell carcinoma: Complete pathological response in a patient with gastric metastasis of renal cell carcinoma

    Anti-Cancer Drugs, Vol. 21, Núm. SUPPL.1

2009

  1. MicroRNAs as circulating tumor cells biomarkers in gastrointestinal cancer

    EJC SUPPLEMENTS

  2. The role of COX-2 in prostate carcinoma: Therapeutical implications

    Handbook of Prostate Cancer Cell Research: Growth, Signalling, and Survival (Nova Science Publishers, Inc.), pp. 363-388

2008

  1. Diagnosis value of EGFR gene expression for early diagnosis in oral leukoplakias

    EJC SUPPLEMENTS

  2. Effectiveness of COX2 inhibitor treatment in patients with dysplastic oral leukoplakia

    EJC SUPPLEMENTS

  3. Origin of renal cell carcinomas

    Clinical and Translational Oncology, Vol. 10, Núm. 11, pp. 697-712

  4. Utility of p53 gene expression for early diagnosis in oral leukoplakias

    EJC SUPPLEMENTS

2007

  1. Choroid plexus carcinoma: A rare condition and its therapeutic management

    Clinical and Translational Oncology, Vol. 9, Núm. 6, pp. 401-403

  2. Cyclooxygenase-2 (COX-2): A molecular target in prostate cancer

    Clinical and Translational Oncology, Vol. 9, Núm. 11, pp. 694-702

  3. Gemcitabine plus docetaxel as first-line chemotherapy in patients with advanced non-small cell lung cancer: A lung cancer Galician group phase II study

    Cancer Chemotherapy and Pharmacology, Vol. 60, Núm. 5, pp. 725-732

  4. Non-seminomatous germ-cell tumour associated with acute megakaryoblastic leukaemia

    Clinical and Translational Oncology, Vol. 9, Núm. 5, pp. 329-331

  5. Prostate cancer and Hedgehog signalling pathway

    Clinical and Translational Oncology, Vol. 9, Núm. 7, pp. 420-428